Physician profile
Janine Miller
NPI 1821291402
$1,050.08
in general payments reported to CMS, 2019-2025
13 companies · $607 in 2025
The $607 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.67 · 2023: $31.80 · 2024: $350 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $988.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $187.24 | 2024-2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $158.87 | 2024 | Zoryve |
| Revance Therapeutics, INC. | $145.83 | 2025 | Daxxify |
| Lilly USA, LLC | $127.04 | 2021-2025 | Ebglyss, Zepbound, Mounjaro |
| Ucb, INC. | $111.76 | 2025 | Bimzelx |
| Abbvie INC. | $78.95 | 2021-2024 | |
| Genzyme Corporation | $77.90 | 2025 | |
| Novartis Pharmaceuticals Corporation | $39.33 | 2025 | |
| Amgen INC. | $32.98 | 2025 | Otezla |
| Solta Medical, A Division of Bausch Health US, LLC | $25.00 | 2024 | |
| Leo Pharma INC. | $24.17 | 2025 | Anzupgo |
| Regeneron Healthcare Solutions, INC. | $21.58 | 2025 | Dupixent |
| Galderma Laboratories, L.P. | $19.43 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janine Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.